thalassemia

(redirected from Beta-thalassemia)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Beta-thalassemia: Alpha-thalassemia, Thalassemia minor

thal·as·se·mi·a

 (thăl′ə-sē′mē-ə)
n.
An inherited form of anemia occurring chiefly among people of Mediterranean descent, caused by faulty synthesis of part of the hemoglobin molecule. Also called Mediterranean anemia.

[Greek thalassa, sea + -emia.]

thal′as·se′mic adj.

thal•as•se•mi•a

(ˌθæl əˈsi mi ə)

n.
a hereditary anemia marked by the abnormal production of hemoglobin, occurring chiefly in people of Mediterranean origin.
[1932; < Greek thálass(a) sea (alluding to the Mediterranean Sea) + -emia]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.thalassemia - an inherited form of anemia caused by faulty synthesis of hemoglobin
monogenic disease, monogenic disorder - an inherited disease controlled by a single pair of genes
hypochromic anaemia, hypochromic anemia - anemia characterized by a decrease in the concentration of corpuscular hemoglobin
Cooley's anaemia, Cooley's anemia, thalassaemia major, thalassemia major - a fatal form of homozygous thalassemia (inherited from both parents) in which there is no hemoglobin; skeletal deformations; heart and spleen and liver enlarged
Translations

thal·as·se·mi·a

, thalassanemia
n. talasemia, grupo de diferentes tipos de anemia hemolítica hereditaria encontrada en poblaciones de la región mediterránea y sureste de Asia;
major ______ mayor;
minor ______ menor.

thalassemia

n talasemia
References in periodicals archive ?
M2 PHARMA-March 9, 2018-Protagonist Therapeutics Receives Orphan Drug Designation from FDA for PTG-300 for Treatment of Beta-Thalassemia
M2 EQUITYBITES-March 7, 2018-Protagonist Therapeutics passes US FDA orphan drug designation for PTG-300 to treat beta-thalassemia
reported that TSH and FT4 were found to be higher in beta-thalassemia patients than in the control group but FT3 was similar in both groups.
We made significant progress advancing our pipeline with the initiation of the Phase 1/2a trial for BIVV001 and the FDA's acceptance of an IND application for ST-400, a gene-edited cell therapy candidate to treat beta-thalassemia being developed in collaboration with Sangamo Therapeutics.
A 12-year preventive program for beta-thalassemia in Northern Sardinia.
The team used base editing or "chemical surgery" to change a single error in the genetic code which causes the blood disease beta-thalassemia.
Mutation Spectrum of beta-Thalassemia and Other Hemoglobinopathies in Chittagong, Southeast Bangladesh.
Diagnosis of beta-thalassemia trait was made in 58 out of 315 (18.
Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major.
Riaz T, Riaz H, Hasan M: Frequency of hypothyroidism in patients with beta-thalassemia major.
Jude Childrens Research Hospital has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia in blood cells isolated from patients.